Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
Troels YndigegnBertil LindahlKatarina MarsJoakim AlfredssonJocelyne BenatarLisa BrandinDavid ErlingeOla HallenClaes HeldPatrik HjalmarssonPelle JohanssonPatric KarlströmThomas KellerthToomas MarandiAnnica Ravn-FischerJohan SundströmOllie ÖstlundRobin HofmannTomas Jernbergnull nullPublished in: The New England journal of medicine (2024)
Among patients with acute myocardial infarction who underwent early coronary angiography and had a preserved left ventricular ejection fraction (≥50%), long-term beta-blocker treatment did not lead to a lower risk of the composite primary end point of death from any cause or new myocardial infarction than no beta-blocker use. (Funded by the Swedish Research Council and others; REDUCE-AMI ClinicalTrials.gov number, NCT03278509.).
Keyphrases
- ejection fraction
- acute myocardial infarction
- aortic stenosis
- left ventricular
- angiotensin converting enzyme
- heart failure
- percutaneous coronary intervention
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- mitral valve
- angiotensin ii
- transcatheter aortic valve replacement
- left atrial
- aortic valve
- smoking cessation